University of Michigan Rogel Cancer Center — Ann Arbor, Michigan

University of Michigan Rogel Cancer Center is a clinical research site located in Ann Arbor, Michigan, United States 48109.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Michigan Rogel Cancer Center has participated in 253 clinical trials with 185 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), EMD Serono Research & Development Institute, Inc., University of Michigan Rogel Cancer Center.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Ann Arbor

Browse all research sites in Michigan · View every site in Ann Arbor

• University of Michigan A. Alfred Taubman Health Care Center
• University of Michigan Comprehensive Cancer Center /ID# 207177
• CFF Pediatric Program University of Michigan
• University of Michigan-Ann Arbor, Cystic Fibrosis Center
• C S Mott Children's Hospital
• Lieutenant Colonel Charles S. Kettles VA Medical Center - Oncology
• University of Michigan Health System Allergy Specialty Clinic
• MedSport - University of Michigan
• University of Michigan Health System Clinical Trials Office
• University of Michigan Ann Arbor
• University of Michigan School of Public Health
• VA Ann Arbor Health Care System

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Michigan Rogel Cancer Center?

University of Michigan Rogel Cancer Center has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Michigan Rogel Cancer Center conducted?

University of Michigan Rogel Cancer Center has 253 clinical trials on record, with 185 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is University of Michigan Rogel Cancer Center accredited by Crixeo Clinical Trials?

University of Michigan Rogel Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Michigan Rogel Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.